Schedule 13G ownership disclosure

Protara Therapeutics Inc

Common Stock · CUSIP: 74365U107

Event date: 2025-03-31

Filing-level shares
1,730,000.00
Percent of class
4.71%
  • Opaleye Management, Inc.

    Shares: 1,730,000.00 · Class: 4.71%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-006421
Form type
SCHEDULE 13G/A
Filer
Opaleye Management Inc.
CIK
CIK 1595855
Filed
Apr 28, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub